Effects of intrathecal amylin on formalin-induced nociception and on cAMP accumulation in the rat embryonic spinal cells
-
Add time:08/31/2019 Source:sciencedirect.com
Amylin (AMY) is a member of calcitonin family of peptides. In this study, the effects of intrathecal (i.t) injection of AMY on the inflammatory pain and on the cAMP accumulation in the rat spinal cells were investigated. By using AMY receptor antagonists, we also studied the pharmacology of AMY receptors in the spinal cells. Formalin model of inflammatory pain was induced by intraplantar injection of formalin. AMY (0.06250–2500 pmol/rat) was administrated i.t 15 min before the injection of formalin. Antagonists were injected i.t 10 min before the injection of AMY and/or morphine. AMY reduced formalin-induced pain in a dose dependent mode. This effect was inhibited by the potent AMY antagonist, AC187 but not CGRP8-37. rAMY8-37, most commonly reported as a weak AMY antagonist, showed to be equally or more potent than AC187 in antagonizing the above effects. The opioid antagonist, naloxone, had no significant effects on AMY antinociceptive effects. Primary dissociated cell culture was used to investigate the effect of AMY on cAMP production and to characterize AMY receptors in the spinal cells. AMY moderately increases cAMP accumulation in the spinal cells with an EC50 value of 74.62 nM. This effect was not affected by CGRP8-37 but was inhibited by AC187 and rAMY8-37 with pA2 values of 7.94 and 7.87 respectively.In conclusion, effects of AMY in reducing formalin induced pain and on the cAMP accumulation by spinal cells are mediated through undefined receptors.
We also recommend Trading Suppliers and Manufacturers of AMYLIN (8-37) (RAT) (cas 138398-61-5). Pls Click Website Link as below: cas 138398-61-5 suppliers
Prev:BZ043, a novel long-acting amylin analog, reduces gastric emptying, food intake, glycemia and insulin requirement in streptozotocin-induced diabetic rats
Next:Amylin receptor ligands reduce the pathological cascade of Alzheimer's disease) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Amylin receptor ligands reduce the pathological cascade of Alzheimer's disease09/01/2019
- BZ043, a novel long-acting amylin analog, reduces gastric emptying, food intake, glycemia and insulin requirement in streptozotocin-induced diabetic rats08/30/2019
- Clinical TrialA dual amylin and calcitonin receptor agonist inhibits pain behavior and reduces cartilage pathology in an osteoarthritis rat model08/29/2019
- Original articleThe protective effect of Azadirachta excelsa leaves extract and quercetin treatment on the learning and memory impairments in relation with insulin and amylin levels in the brain of streptozotocin-induced diabetic rats08/28/2019
- Protein aggregates and proteostasis in aging: Amylin and β-cell function08/27/2019
- ReviewAmylin – Its role in the homeostatic and hedonic control of eating and recent developments of amylin analogs to treat obesity08/26/2019
- Amylin and diabetic cardiomyopathy – amylin-induced sarcolemmal Ca2 + leak is independent of diabetic remodeling of myocardium☆08/25/2019
- Focused reviewInteraction of amylin species with transition metals and membranes08/24/2019
- Fibril formation and toxicity of the non-amyloidogenic rat amylin peptide08/23/2019


